Skip to main content

VANGUARD GROUP INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 102909 Valley Forge, PA

Position in NBIX

as of Dec 31, 2025 · filed Jan 29, 2026
Position Value
$1,375,793,688
+$13,186,938 QoQ
Shares Held
9,700,301
-0.1% QoQ
Ownership
9.65%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 6.8324683945374485.ToString("F0")% None 93.16753160546256.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Dec 31, 2025

VANGUARD GROUP INC holds $16,658,868,137 across 58 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (8.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
9,700,301 $1,375,793,688

All Filings in NBIX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2025-12-31 $1,375,793,688 9,700,301
2025-09-30 $1,362,606,750 9,706,559
2025-06-30 $1,232,650,123 9,807,066
2025-03-31 $1,099,572,700 9,941,887
2024-12-31 $1,381,330,995 10,119,641
2024-09-30 $1,151,849,730 9,996,960
2024-06-30 $1,384,470,918 10,056,446
2024-03-31 $1,369,673,311 9,930,926
2023-12-31 $1,279,432,815 9,710,328
2023-09-30 $1,075,482,337 9,559,843
2023-06-30 $902,518,705 9,570,718
2023-03-31 $971,462,187 9,597,532
2022-12-31 $1,115,604,832 9,340,295
2022-09-30 $955,992,277 9,000,963
2022-06-30 $868,008,123 8,904,474
2022-03-31 $822,886,686 8,777,458
2021-12-31 $748,473,192 8,787,991
2021-09-30 $852,493,156 8,888,470
2021-06-30 $874,383,314 8,984,621
2021-03-31 $858,646,993 8,829,275
2020-12-31 $799,126,848 8,337,265
2020-09-30 $784,813,009 8,161,533
2020-06-30 $1,034,479,358 8,479,339
2020-03-31 $735,994,194 8,503,688